Background: Among the goals of gestational asthma, therapy is optimisation of pulmonary function. According to the US Food and Drug Administration, no asthma drugs can be considered ‘safe’ during pregnancy. Fear of adverse fetal effects may thus lead to restrictive use of asthma drugs during pregnancy, and no population-based studies concerning gestational asthma therapy exist. Objectives: To examine whether asthma drugs or changing intensity of asthma therapy during pregnancy was associated with deviations from expected values of gestational age, birth weight, length at birth, or malformations. Methods: The Birth Registry was used to identify all 15,756 primiparous women who gave birth in the County of North Jutland between 1991 and 1996. According to the North Jutland Prescription Database, 303 of these women received prescriptions for asthma drugs during pregnancy. Women who did not purchase any prescription drugs during pregnancy constituted the reference group. Conclusion: Women who received prescriptions for asthma drugs during pregnancy gave birth to infants with birth weight and length at birth within the expected limits. Reducing intensity of asthma treatment during pregnancy was associated with lower birth weight and length at birth. This may indicate that pregnant women chose to discontinue therapy although their disease severity justifies continuation of treatment. However, analyses did not take into account important clinical variables, and results could also be due to confounding factors or chance.

Keywords:
Asthma, Drugs, Pregnancy, Prescription study, population-based
1.
Schatz M, Hoffman CP, Zeiger RS, Falkoff R, Macy E, Mellon M: The course and management of asthma and allergic diseases during pregnancy; in Middleton E, Ellis EF, Yunginger JW, Reed CE, Adkinson NF, Busse WW (eds): Allergy. Principles and Practice, ed 5. Missouri, Mosby, 1999, pp 938–952.
2.
Alexander S, Dodds L, Armson BA: Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 1998;92:435–440.
3.
Gordon M, Niswander KR, Berendes H, Kantor AG: Fetal morbidity following potentially anoxigenic obstetric conditions. Am J Obstet Gynecol 1970;106:421–429.
4.
Bahna SL, Bjerkedal T: The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol 1972;27:397–406.
5.
Moore GL, Rounds DJ, Grover RF, Reeves JT: Infant birth weight is related to maternal arterial oxygenation at high altitude. J Appl Physiol Respirat Environ Exercise Physiol 1982;52:695–699.
6.
Greenberger PA, Patterson R: Management of asthma during pregnancy. N Engl J Med 1985;312:897–902.
7.
Schatz M: Asthma and pregnancy. Lancet 1999;353:1202–1204.
8.
Czeicel AE: Recommendation to avoid all drugs during first trimester is unrealistic. BMJ 1996;313:424–425.
9.
Schatz M, Zeiger RS, Hoffman CP, and the Kaiser Permanente Asthma and Pregnancy Study Group: Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Chest 1990;98:389–392.
10.
Briggs GG, Freeman RK, Summer JY, Mitchell CW (eds): Drugs in Pregnancy and Lactation, ed 4. Baltimore, Williams & Wilkins, 1997.
11.
Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938–941.
12.
Benediktsson R, Lindsay R, Noble J, Seckl JR, Edwards CRW: Glucocorticoid exposure in utero: A new model for adult hypertension. Lancet 1993;341:339–341.
13.
Levine RS, Hennekens CH, Jesse MJ: Blood pressure in prospective population based cohort of newborn and infant twins. BMJ 1994;308:298–302.
14.
Whincup PH, Cook D, Papacosta O, Walker M: Birth weight and blood pressure: Cross-sectional and longitudinal relations in childhood. BMJ 1995;311:773–776.
15.
Edwards CRW, Benediktsson R, Lindsay R, Seckl JR: Dysfunction of the placental glucocorticoid barrier: A link between the foetal environment and adult hypertension? Lancet 1993;341:355–357.
16.
Nielsen GL, Sørensen HT, Weijin Z, Steffensen FH, Olsen JH: The Pharmacoepidemiologic Prescription Database of North Jutland. Int J Risk Safety Med 1997;10:203–205.
17.
Sundhedsstyrelsen: Danish Classification of Diseases, revision 8. Schultz Grafisk A/S 1988. ISBN 87–503–6309–5.
18.
Sundhedsstyrelsen: International Classification of Diseases and Health Related Problems, revision 10. Copenhagen, Munksgaard, 1993. ISBN 87–16–11932–0.
19.
Drug Utilization Studies. Methods and Uses. Introduction. WHO Regional Publications, European Series, No 45, 1993.
20.
Gaist D, Hallas J, Hansen NC, Gram LF: Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994. Br J Clin Pharmacol 1996;41:285–289.
21.
British Thoracic Society and others: Guidelines for the management of asthma: A summary. BMJ 1993;306:776–782.
22.
Danish Drug Catalogue. Copenhagen, Danish Drug Information A/S, 1998.
23.
Perlow JH, Montgomery D, Morgan MA, Towers CV, Porto M: Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992;167:963–967.
24.
Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar L, Petitti D: The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997;100:301–306.
25.
Stenius AB, Piirila P, Teramo K: Asthma and pregnancy: A prospective study of 198 pregnancies. Thorax 1988;43:12–18.
26.
Lao TT, Huengsburg M: Labour and delivery in mothers with asthma. Eur J Obstet Gynecol 1990;35:183–190.
27.
Jana N, Vasishta K, Saha SC, Khunnu B: Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome. J Obstet Gynaecol 1995;21:227–232.
28.
Minerbi Codish I, Fraser D, Avnun L, Glezerman M, Heimer D: Influence of asthma in pregnancy on labor and the newborn. Respiration 1998;65:130–135.
29.
Park JM, Schmer V, Mayers TL: Cardiovascular anomalies associated with prenatal exposure to theophylline. South Med J 1990;83:1487–1488.
30.
Stenius AB, Riikonen S, Teramo K: Slow-release theophylline in pregnant asthmatics. Chest 1995;107:642–647.
31.
Schatz M: Pregnancy and asthma. J Asthma 1997;34:263–264.
32.
Schatz M: Asthma treatment during pregnancy. What can be safely taken? Drug Saf 1997;16:342–350.
33.
Stenius AB, Hedman J, Teramo KA: Acute asthma during pregnancy. Thorax 1996;51:411–414.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.